The Phylum Bryozoa: From Biology to Biomedical Potential
Open Access
- 9 April 2020
- journal article
- review article
- Published by MDPI AG in Marine Drugs
- Vol. 18 (4), 200
- https://doi.org/10.3390/md18040200
Abstract
Less than one percent of marine natural products characterized since 1963 have been obtained from the phylum Bryozoa which, therefore, still represents a huge reservoir for the discovery of bioactive metabolites with its ~6000 described species. The current review is designed to highlight how bryozoans use sophisticated chemical defenses against their numerous predators and competitors, and which can be harbored for medicinal uses. This review collates all currently available chemoecological data about bryozoans and lists potential applications/benefits for human health. The core of the current review relates to the potential of bryozoan metabolites in human diseases with particular attention to viral, brain, and parasitic diseases. It additionally weighs the pros and cons of total syntheses of some bryozoan metabolites versus the synthesis of non-natural analogues, and explores the hopes put into the development of biotechnological approaches to provide sustainable amounts of bryozoan metabolites without harming the natural environment.Keywords
This publication has 229 references indexed in Scilit:
- A molecular phylogeny of bryozoansMolecular Phylogenetics and Evolution, 2012
- Lessons from the Past and Charting the Future of Marine Natural Products Drug Discovery and Chemical BiologyCell Chemical Biology, 2012
- Highlights of marine invertebrate-derived biosynthetic products: Their biomedical potential and possible production by microbial associantsBioorganic & Medicinal Chemistry, 2011
- Total Synthesis of Bryostatin 9Journal of the American Chemical Society, 2011
- Translating Nature’s Library: The Bryostatins and Function‐Oriented SynthesisIsrael Journal of Chemistry, 2011
- Polyketide β-Branching in Bryostatin Biosynthesis: Identification of Surrogate Acetyl-ACP Donors for BryR, an HMG-ACP SynthaseCell Chemical Biology, 2010
- Engineered polyketide biosynthesis and biocatalysis in Escherichia coliApplied Microbiology and Biotechnology, 2010
- Assessing Pressurized Liquid Extraction for the High-Throughput Extraction of Marine-Sponge-Derived Natural ProductsJournal of Natural Products, 2009
- In Vivo and In Vitro Trans-Acylation by BryP, the Putative Bryostatin Pathway Acyltransferase Derived from an Uncultured Marine SymbiontCell Chemical Biology, 2008
- The evolving role of natural products in drug discoveryNature Reviews Drug Discovery, 2005